None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were hospitalized and treated for cerebrovascular disease (I60, I61, I63) at Kyung Hee University Korean Medicine Hospital from January 01, 2015 to December 31, 2019 ( 65 years of age or older). It must satisfy the criteria of A or B below. A: In case of hospitalization after 21 days of onset of cerebrovascular disease B: Case hospitalized for more than 21 days immediately after onset of cerebrovascular disease
Exclusion criteria
Exclusion criteria: Patients with degenerative brain diseases (eg, Parkinson's disease, Alzheimer's disease, etc.), brain tumors, and other brain diseases such as traumatic brain injury.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the frequency of polypharmacy, potentially inappropriate medications and underuse before and after the use of oriental medicine treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between “improving the frequency of polypharmacy” and “improving the frequency of potentially inappropriate medications or underuse” before and after the combination of Korean medicine treatment;Comparison of improvement in National Institute of Health Stroke Scale (NIHSS) according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of improvement in modified Barthel Index (mBI) according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of improvement in cognitive impairment according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of frequency of liver function abnormality according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of frequency of renal function abnormality according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Analysis of factors affecting “improvement of polypharmacy, potentially inadequate prescription, and underuse” | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Oriental Medical Center